Brygida Adamek

Brygida Adamek

Auto-generated profile, based on publicly available information

Brygida Adamek

Department of Basic Medical Sciences, School of Public Health in Bytom, Medical University of Silesia, Katowice, Poland

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2008 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
Agata StanekAgata Stanek
Agata Stanek
AGA. Gadowska-Cicha
A. Gadowska-Cicha
KGK. Gawron
K. Gawron
TWT. Wielkoszynski
T. Wielkoszynski
BAB. Adamek
B. Adamek
ASA. Sieron
A. Sieron
In this paper the physiological role of NO and isoforms of NOS in the gastrointestinal tract and the involvement of NO in pathological processes of digestive tract as well as the perspective of therapeutic use of NO-donating drugs and selective inhibitors of phosphodiesterase in the treatment of gastric diseases were presented.

1 January 2013 in Medical Science Monitor
Verified
Journal Article
Open access
PDF file
AWAndrzej Wiczkowski
Andrzej Wiczkowski
APAnna Płachetka
Anna Płachetka
BABrygida Adamek
Brygida Adamek
Joanna Katarzyna StrzelczykJoanna Katarzyna Strzelczyk
Joanna Katarzyna Strzelczyk
ŁKŁukasz Krakowczyk
Łukasz Krakowczyk
PNPrzemysław Nowak
Przemysław Nowak
Background:8-hydroxy-2’-deoxyguanosine (8-OHdG) is one of the most abundant oxidatively modified lesions in DNA and is a marker of the oxidative stress. 8-OHdG is a mutagenic lesion and it can mispair with adenine, causing G: C→T: A transversion....

27 November 2012 in Acta Biochimica Polonica
Verified
Journal Article
Open access
PDF file
Joanna Katarzyna StrzelczykJoanna Katarzyna Strzelczyk
Joanna Katarzyna Strzelczyk
TWTomasz Wielkoszyński
Tomasz Wielkoszyński
ŁKŁukasz Krakowczyk
Łukasz Krakowczyk
BABrygida Adamek
Brygida Adamek
MZMarzena Zalewska-Ziob
Marzena Zalewska-Ziob
AWAndrzej Wiczkowski
Andrzej Wiczkowski
Oxidative stress is one of several factors which contribute to the development of colorectal carcinogenesis. The aim of the study was an assessment of the activity of antioxidant enzymes in tumour and corresponding normal distal mucosa in a group of patients with colorectal adenocarcinoma. Samples of tumour and corresponding normal mucosa were obtained during a resection of colorectal cancer from 47 patients aged between 26 and 82 years. The average distance of corresponding normal distal mucosa from the tumour was 4.49 cm. Activities of antioxidant enzymes: superoxide dismutase (SOD), glutathione reductase (GR), glutathione peroxidase (GPx), glutathione S-transferase (GST), and catalase (CAT) were measured in tissue homogenates. The patients were grouped according to the tumour stage (Duke's staging), grading, localization, and size of tumour, as well as age and sex. Statistical analysis was performed. The activity of SOD and GPx was considerably increased, while the activity of GST decreased significantly in tumour as compared with normal mucosa. GR activity in colorectal cancer was evidently higher in tumours of proximal location compared with the distal ones. The distance of corresponding normal distal mucosa from the tumour was analyzed and related to all assayed parameters. A decreased GST activity was observed in corresponding normal mucosa more than 5 cm distant from the tumour in patients with CD Duke's stage. The higher activity of superoxide dismutase and glutathione peroxidase in tumour compared to corresponding normal mucosa could indicate higher oxidative stress in colorectal adenocarcinoma cells.

10 July 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
Michael KuklaMichael Kukla
Michael Kukla
BABrygida Adamek
Brygida Adamek
MWMarek Waluga
Marek Waluga
MZMarzena Zalewska-Ziob
Marzena Zalewska-Ziob
JKJanusz Kasperczyk
Janusz Kasperczyk
MHMarek Hartleb
Marek Hartleb
Introduction. Chemerin seems to be involved in pathogenesis of chronic hepatitis C (CHC). Hepatic expressions of chemerin and its receptor, chemokine receptor-like 1 (CMKLR1), in CHC have not been studied so far.Aim. To evaluatechemerinandCMKLR1hepatic expression together with serumchemerinconcentration in CHC patients and to assess their relationship with metabolic and histopathological abnormalities.Methods. The study included 63 nonobese CHC patients. Transcription ofchemerinandCMKLR1was assessed by quantitative real-time PCR, while serum chemerin was assessed by enzyme-linked immunosorbent assay.Results. Expression ofchemerinandCMKLR1was present in the liver of all CHC patients regardless of sex or age. This expression was not associated with necroinflammatory activity and steatosis grade, fibrosis stage, and metabolic abnormalities. There was a negative association between serum chemerin andchemerinhepatic expression (r= (−0.41),P= 0.006).Conclusion. The study for the first time confirmed a marked expression ofchemerinandCMKLR1in the liver of CHC patients. The study was performed using the homogenates of human liver tissue, so it is not possible to define whether hepatocytes or other cell types which are abundantly represented in the liver constitute the main source ofchemerinandCMKLR1mRNA.

1 January 2017 in Clinical and Experimental Hepatology
Verified
Journal Article
Open access
BABrygida Adamek
Brygida Adamek
MZMarzena Zalewska-Ziob
Marzena Zalewska-Ziob
Joanna Katarzyna StrzelczykJoanna Katarzyna Strzelczyk
Joanna Katarzyna Strzelczyk
JKJanusz Kasperczyk
Janusz Kasperczyk
KWKinga Wołkowska-Pokrywa
Kinga Wołkowska-Pokrywa
ZOZofia Ostrowska
Zofia Ostrowska
Introduction : Liver regeneration is a complex, highly coordinated process which can be disturbed by the impact of the anti-proliferative interferon α activity. In the model of partial hepatectomy (PH) in the rat the expression of HGF and EGF genes and their molecules’ tissue concentrations...

23 October 2015 in Polish Journal of Pathology
Verified
Journal Article
Open access
Michael KuklaMichael Kukla
Michael Kukla
MWMarek Waluga
Marek Waluga
BABrygida Adamek
Brygida Adamek
MZMarzena Zalewska-Ziob
Marzena Zalewska-Ziob
JKJanusz Kasperczyk
Janusz Kasperczyk
MHMarek Hartleb
Marek Hartleb
Chronic hepatitis C (CHC) is accompanied by numerous metabolic disorders, partially associated with altered adipokine system regulation. Omentin (intelectin-1) is a novel adipokine known to play a pivotal role in metabolic regulation in CHC. In a group of 63 CHC patients (29 men/34 women) infected with genotype 1b, aged 6.6 ±14.6 years, serum omentin levels and its gene expression in liver tissue were examined and their association with metabolic and histopathological features was assessed. Serum omentin levels were significantly higher in CHC patients compared to controls (p < 0.001), regardless of sex, body mass index (BMI), insulin sensitivity and lipid concentrations. There was no correlation between serum omentin and omentin hepatic expression. Neither parameter was associated with any histological features. Serum omentin in non-obese CHC patients seems not to be related to metabolic disorders or liver pathology. Omentin hepatic expression shows no relationship with either serum omentin levels or histopathological features. This suggests different mechanisms regulating circulating omentin concentration and omentin hepatic expression in CHC.